TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ENGN

enGene Holdings Inc.

Healthcare · Biotechnology

2.00$ -1.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

enGene Holdings Inc. (ENGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -99 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ENGN
Line item 2020 2021 2022 2023 2024 2025
-13 -16 -18 -25 -48 -99
0.3 0.3 0.2 0.2 0.3 0.5
0.2 0.4 0.1 3.5 5.3 9.6
0.4 -1.0 2.2 -0.5 0.1 9.7
0.2 0.2 0.2 0.3 0.9 1.5
-0.2 -0.2 -0.2 -0.3 -126 -25
– 7.1 28 33 13 -0.7
13 23 28 86 266 1.5
-0.5 6.4 9.4 61 91 -123
-13 -16 -18 -25 -49 -101

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?